COLL.US Collegium Pharmaceutical Inc

Healthcare Pharmaceuticals USA Stocks
25.32 USD
Close of Nov 14, 2026
21.43 50.79
Market cap
USD 787M
P/E
23.2x
P/B
2.62x
ROE
9.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is COLL.US undervalued?

Graham number
Price25.32
Graham value15.40
Premium64.5%

COLL.US trades 64.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Collegium Pharmaceutical Inc fundamental analysis

No fundamental analysis for Collegium Pharmaceutical Inc yet.

Collegium Pharmaceutical Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtam…

Full company profile